Association of gene expression signatures and TMB with response to pembrolizumab (pembro) in patients (pts) with recurrent ovarian cancer (ROC) enrolled in KEYNOTE-100

Autores: Ledermann, J. A.; Shapira-Frommer, R. ; Santin, A. D.; Lisyanskaya, A.; Pignata, S. ; Vergote, I. B.; Raspagliesi, F.; Sonke, G. S. ; Birrer, M. ; Provencher, D.; Sehouli, J. ; Colombo, N.; González Martín, Antonio; Oaknin, A.; Saadatpour, A. ; Kobie, J.; Jelinic, P.; Stein, K.; Matulonis, U. A.